Drug Database
Back to search

Netherlands· NL-8d8e83572c4d

Tranylcypromine Milstein 10 mg, omhulde tabletten

A tranylcypromine product containing tranylcyprominesulfaat, registered in Netherlands by Milstein C.V.. The same ATC class is registered in 12 of our 19 countries.

ATC N06AF04

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedTranylcypromine Milstein 10 mg, omhul…ATCN06AF04REGISTER NO.NL-8d8e83572c4dPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tranylcyprominesulfaatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tranylcypromine is registered in 12 of 19 countries.

Countries holding a registration under ATC N06AF04 (tranylcypromine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose
Search tranylcypromine products by name

Tranylcypromine · ATC N06AF04

12 / 19 countries

  • Canada
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TRANYLCYPROMINESULFAAT
Manufacturer
Milstein C.V.
Country
Netherlands (NL)
ATC code
N06AF04
ATC class
Tranylcypromine
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    116661

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

197 interactions on record for tranylcypromine.

Graded by severity as the source publishes them — 45 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tranylcypromine against other medicinesHow interaction checks work

Tranylcypromine · interactions on record

197 records

  • 45 severe
  • 134 moderate
  • 11 minor
  • 7 info

Most severe, free to view

  • IsomethepteneA03AX10severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • DolasetronA04AA04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tranylcypromine in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tranylcypromine products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Austria · Tranylcypromin Aristo
  • Germany · Jatrosom, Tranylcypromin Aristo
  • Denmark · Abbonate, Tranylcypromin Holsten
  • Spain · Tranilcipromina Aristo
  • Finland · Abbonate
  • United Kingdom (Northern Ireland) · Parnate, Tranylcypromine
  • Ireland · Parnate, Tranylcypromine Eignapharma
  • Iceland · Abbonate
  • Norway · Abbonate, Tranylcypromine Afortas
  • Sweden · Abbonate, Tranylcypromin Holsten

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a4c03fe8-33dd-4043-bb87-42d76b728d43
GET /v1/drugs/a4c03fe8-33dd-4043-bb87-42d76b728d43?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Omhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h116661_smpc.pdf",
  "strength": null,
  "atc_label": "Tranylcypromine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg116661",
  "excipients": [
    "ASPARTAAM (E 951)",
    "CALCIUMCARBONAAT (E 170)",
    "CALCIUMSULFAAT 2-WATER (E 516)",
    "CARMELLOSE NATRIUM (E 466)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "MACROGOL 6000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MONOGLYCERIDEN, GEDIACETYLEERD",
    "PONCEAU 4R (E 124)",
    "POVIDON (E 1201)",
    "SACCHAROSE",
    "SCHELLAK (E 904)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)",
    "ZETMEEL, GEPREGELATINEERD"
  ],
  "substances": [
    "TRANYLCYPROMINESULFAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h116661.pdf",
  "authorised_at": "2016/11/16",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "116661",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about tranylcypromine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console